Stockreport

Tonix up big on start of late-stage study of TNX-102 SL; shares ahead 66% premarket [Seeking Alpha]

Tonix Pharmaceuticals Holding Corp.  (TNXP) 
Last tonix pharmaceuticals holding corp. earnings: 3/24 05:15 pm Check Earnings Report
US:NASDAQ Investor Relations: tonixpharma.com
PDF Investors are downright giddy over Tonix Pharmaceuticals' (NASDAQ: TNXP ) start of a Phase 3 clinical trial assessing TNX-102 SL in PTSD. Shares are up  premarket [Read more]